The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Stergiou Angelos M. since 2019.
This trader's CIK number is 1724253.
At the time of last reporting, Stergiou Angelos M. was the President and CEO of Sellas Life Sciences Group, Inc.. (stock ticker symbol SLS).
Also see all insider trading activities at Sellas Life Sciences Group, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | SLS | 0 | $0 | 6,494 | $16,936 | 0 | $0 |
| 2021 | SLS | 0 | $0 | 2,120 | $13,252 | 0 | $0 |
| 2018 | SLS | 0 | $0 | 23,277 | $29,189 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-12-05 | SLS | Sale | 6,494 | 2.61 | 16,936 |
| 2021-12-02 | SLS | Sale | 2,120 | 6.25 | 13,252 |
| 2018-12-31 | SLS | Sale | 23,277 | 1.25 | 29,189 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stergiou Angelos M. (President and CEO of Sellas Life Sciences Group, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.